首页> 外文期刊>Antimicrobial agents and chemotherapy. >A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever.
【24h】

A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever.

机译:阿奇霉素和氧氟沙星治疗耐多药或耐萘啶酸的肠热的随机对照比较。

获取原文
获取原文并翻译 | 示例
           

摘要

To examine the efficacy and safety of short courses of azithromycin and ofloxacin for treating multidrug-resistant (MDR, i.e., resistant to chloramphenicol, ampicillin, and cotrimoxazole) and nalidixic acid-resistant enteric fever, azithromycin (1 g once daily for 5 days at 20 mg/kg/day) and ofloxacin (200 mg orally twice a day for 5 days at 8 mg/kg/day) were compared in an open randomized study in adults admitted to a hospital with uncomplicated enteric fever. A total of 88 blood culture-confirmed patients were enrolled in the study (86 with Salmonella enterica serovar Typhi and 2 with S. enterica serovar Paratyphi A). Of these, 44 received azithromycin and 44 ofloxacin. A total of 68 of 87 (78%) isolates were MDR serovar Typhi, and 46 of 87 (53%) were nalidixic acid resistant. The MIC(90) (range) of azithromycin was 8 (4 to 16) microgram/ml for the isolates. The MIC(90) (range) of ofloxacin for the nalidixic acid-sensitive isolates was 0.03 (0.015 to 0.06) microgram/ml and for the nalidixic acid-resistant isolates it was 0.5 (0.25 to 1.0) microgram/ml. There was no significant difference in the overall clinical cure rate with ofloxacin and azithromycin (38 of 44 [86.4%] versus 42 of 44 [95.5%]; P = 0.27) or in the patients infected with nalidixic acid-resistant typhoid (17 of 21 [81.0%] versus 24 of 25 [96.0%]; P = 0.16). However, patients with nalidixic acid-resistant typhoid treated with ofloxacin had a longer fever clearance time compared with those treated with azithromycin (174 [60 to 264] versus 135 [72 to 186] h; P = 0.004) and had positive fecal cultures after the end of treatment (7 of 17 [41%] versus 0 of 19 [0%]; P = 0.002). Both antibiotics were well tolerated. A 5-day course of azithromycin was effective for the treatment of enteric fever due to MDR and nalidixic-acid-resistant serovar Typhi, whereas the ofloxacin regimen chosen was less satisfactory for these strains.
机译:研究阿奇霉素和氧氟沙星短期疗程对多药耐药性(MDR,即对氯霉素,氨苄青霉素和cotrimoxazole的耐药性)和耐萘啶酸的肠热,阿奇霉素(1 g,每天一次,连续5天)的疗效和安全性在一项开放性随机研究中,比较了20毫克/千克/天和氧氟沙星(每天两次口服200毫克,共8毫克/千克/天,连续5天)在没有并发症肠热的住院患者中进行的比较。共有88位经血液培养证实的患者入选了该研究(86例肠炎沙门氏菌伤寒沙门氏菌,2例肠炎沙门氏菌副伤寒沙门氏菌A例)。其中,有44例接受了阿奇霉素和44项氧氟沙星治疗。在MDR血清型伤寒菌中,共有87个菌株中有68个(占78%),耐萘啶酸的有87个菌株中有46个(占53%)。阿奇霉素的MIC(90)(范围)为8(4至16)微克/毫升。氧氟沙星对萘啶酸敏感的分离物的MIC(90)(范围)为0.03(0.015至0.06)微克/毫升,对于耐萘啶酸的分离物的MIC(90)为0.5(0.25至1.0)微克/毫升。氧氟沙星和阿奇霉素的整体临床治愈率(44的38 [86.4%]与44的42 [95.5%]; P = 0.27)或感染耐萘啶酸的伤寒患者(17例)无显着差异。 21 [81.0%]对比25中的24 [96.0%]; P = 0.16)。然而,与用阿奇霉素治疗的患者相比,用氧氟沙星治疗的耐萘啶酸的伤寒患者的发烧清除时间更长(174 [60至264] h对135 [72至186] h; P = 0.004),并且术后粪便培养阳性治疗结束(17个中的7个[41%]相对于19个中的0 [0%]; P = 0.002)。两种抗生素均耐受良好。阿奇霉素的5天疗程可有效治疗因MDR和耐萘啶酸的血清型鼠伤寒而引起的肠热,而所选用的氧氟沙星方案对这些菌株的疗效较差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号